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CORNISH, H. H. (1972). Toxicol. Appl. Pharmacol. 23, 720-730. The 
methodology for the unequivocal identification of caffeine and 13 possible 
metabolites (mono, di- and tri-l\r-methylated xanthine and uric acid 
derivatives) based on TLC, UV and mass spectrometry has been developed. 
Upon ip administration ofcaffeine-3H to the rat, 64-67 % of the radioactivity 
was recovered in the urine over a period of 24 hr. The chloroform-methanol 
(9:l) extract of the urine accounted for about 37% of the administered 
radioactivity. Water soluble metabolites constitute approximately 30% of 
the injected caffeine-3H. With the aid of preparative TLC, 8.8% of un- 
changed caffeine and the following metabolites were isolated from chloro- 
form-methanol extract of urine: theophylline (1.2x), theobromine (5.1x), 
paraxanthine (8.8%) and trace amounts of 1,3,7-trimethyluric acid and 
3-methyluric acid. Two unidentified metabolites (metabolite A, 11.4 % and 
metabolite B, 1.3 %) have also been isolated. 
Caffeine, a xanthine alkaloid, is being consumed daily by the general public in large 
quantities in beverages such as coffee, tea, cocoa and soft drinks as well as in a number 
of prescription and nonprescription drugs. While caffeine is the most powerful stimu- 
lant of the central nervous system among the methylxanthines, to a lesser degree it 
also acts on the kidney to produce diuresis, stimulates cardiac muscle and relaxes 
smooth muscle. Stimulation of the drug-metabolizing liver microsomal enzymes by 
acute doses of caffeine has been reported by Mitoma et al. (1968). Recently Lombrozo 
and Mitoma (1970) suggested that the effect of caffeine on cytochrome P-450 is similar 
to that of 3-methylcholanthrene. Caffeine causes mutations in human cells in culture 
(Osterstag et al., 1965) and seems to pass into gonadal tissues as well as through the 
placenta into fetal tissues (Goldstein and Warren, 1962). While the inhibition of 
phosphodiesterase by caffeine and the consequent accumulation of cyclic AMP and 
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lipolysis is well documented (Beavo et al., 1971), its possible role as an inhibitor of 
DNA polymerase has also been pointed out (Wragg et al., 1967). The factors affecting 
caffeine toxicity have been recently reviewed (Peters, 1967). 
The absorption, distribution, metabolism and excretion of caffeine in human subjects 
as well as various experimental animals have been studied by several investigators. 
In general, it is rapidly absorbed from the intestinal tract and distributes in the body 
according to tissue water content (Schmidt, 1968; Czok et al., 1968, 1969; Bertoli 
et al., 1968). Warren (1969) has shown that it takes about 7 days to decaffeinate the 
blood of habitual coffee drinkers. This study suggests that there is a possibility of 
storage of caffeine in the tissues of habitual coffee drinkers and that the rate of caffeine 
metabolism differs between the habitual coffee drinkers and the noncoffee drinkers. 
The effect of diet and environment on the distribution of caffeine in rats has also been 
reported (Czok et al., 1968). 
Most of ingested caffeine is reported to be metabolized prior to its excretion. Cornish 
and Christman (1957) found paraxanthine, 1-methylxanthine and I-methyluric acid 
as the major urinary metabolites of caffeine in man and the rabbit. Subsequently, 
theobromine was also reported to be a metabolite of caffeine in man (Schmidt and 
Schoyerer, 1966). In the dog, theophylline has been identified as an additional metabo- 
lite of caffeine (Parke, 1968). 
Otomo (1959) studied the metabolism of caffeine in the rat by injecting it continually 
into the abdominal cavity for a period of 10 days. Otomo found I-methylxanthine. 
theophylline, 1,3-dimethyluric acid, 3-methyluric acid and I-methyluric acid in the 
serum, and I-methylxanthine, 1,3,7-trimethyluric acid, 3-methyluric acid and three 
unknown compounds in the urine as the metabolites of caffeine. 
In all the investigations cited above, caffeine metabolites were identified on the basis 
of chromatographic and UV methods. There appears to be no report in the literature 
on the application of tracer methods to the study of caffeine metabolism encompassing 
the isolation and characterization of the metabolites. The present paper describes the 
metabolic fate of caffeine-3H in the rat. As an adjunct to this study, we have developed 
methods for the isolation of metabolites as well as their unequivocal identification 
based on TLC, UV and mass spectrometry. The 15 possible xanthine and uric acid 
metabolites of caffeine include six mono- and di-l\i-demethylated products (IT-VII); 
xanthine (VIII); seven mono-, di and tri-N-methyluric acids (IX-XV) and uric acid 
(XVI) (Figs. 1 and 2). 
METHODS 
Caffeine-3H, specific activity 1.5 Ci/mmole, uniformly labeled, was purchased from 
Amersham/Searle, Arlington Heights, Illinois. The purity of caffeine-3H was deter- 
mined by TLC in two solvent systems. It was diluted with nonradioactive caffeine to 
contain 0.4 &i/mg (2 @/ml). 
Male rats (Sprague-Dawley strain), weighing 250-300 g were used for this study. 
The rats were injected ip with 4 $i (10 mg) caffeine in 2 ml of distilled water and were 
housed in individual metabolism cages. They were not fed during the course of the 
experiment, but water was given ad libitum. Twenty-four hour urine samples were 
collected and monitored for radioactivity using a liquid scintillation counter. 
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FIG. 2. Uric acid and its N-methylated derivatives. 
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Radioactivity assay. A Packard TriCarb scintillation spectrometer, Model 3375, 
and a Beckman LS-150 liquid scintillation counter were used for radioactive assays. 
These instruments were standardized; the former had an efficiency of 28% whereas 
the latter was 43% efficient. A mixture containing Packard scintillation grade naph- 
thalene (80 g), POP (14.0 g, 2,5-diphenyloxazole), POPOP (50 mg, I,4-bis-2-(4-methyl- 
5-phenyloxazolyl)benzene), and 1,4-dioxane reagent grade (to make 1 liter) was used 
as scintillation fluid. A Packard Radiochromatogram Scanner, Model No. 7201 was 
used for screening TLC plates for radioactivity. 
Chromatography. Precoated TLC sheets, silica gel F-254 on aluminum (Brinkman 
Instruments, Inc.) were used for chromatographic studies. Solvent system A contained 
chloroform-ethanol (9 : 1) and solvent system B was a mixture of chloroform-acetone- 
n-butanol-concentrated ammonium hydroxide (30:30:40:10). Multiple-development 
technique was used to separate the compounds having close R,, values. Authentic 
samples of known compounds were run on the same TLC plate along with the unknown 
metabolites. Ultraviolet light was used to mark the compounds on the TLC plates, 
and the plates were also scanned for radioactive areas. 
Ultraviolet analysis. The radioactive areas were scraped off the thin-layer plates, 
eluted with ethanol-concentrated NH,OH (8: 2) and purified by rechromatography 
on TLC plates using solvent system A. The compounds were eluted with ethanol and 
screened for LJV absorption in the range 220-340 nm with the aid of a Beckman DK-2A 
Spectrophotometer. The reference cell contained an ethanol eluent of blank silica gel 
F-254. A drop of 0.01 N sodium hydroxide solution was added to the ethanol solution 
of the samples for the measurement of absorptions in the alkaline media. 
Mass spectrometry. The mass spectra of the unknown metabolites were recorded on 
an LKB 9000 gc-mass spectrometer at 70 eV electron beam voltage as described earlier 
(Rao et al., 1972). 
Isolation and identification of the metabolites. Urine samples were evaporated to 
dryness in vacua. The residue was suspended in 100 ml of chloroform-methanol (9: I), 
and the suspension was filtered. The filtrate was concentrated by evaporation and 
streaked on two silica gel F-254 plates (20 x 20 cm). The plates were developed in 
solvent system A. Multiple pass techniques were used for better resolution of the 
metabolites. A strip (5 x 20 cm) was cut from each of the plates and scanned for 
radioactive areas (Fig. 2). The radioactive bands were designated with capital letters 
starting with A at the bottom of the plate. These bands were then scraped off the plate 
and eluted with ethanol-concentrated NH,OH (8 : 2). The eluents were concentrated 
by evaporation and purified by rechromatography using solvent system B. The isolated 
metabolites were identified with the aid of TLC, UV and mass spectrometric methods 
described above. 
Quantitation of the metabolites. The pooled urine samples were evaporated to dryness 
in a flash evaporator in vacua. The dried residue was suspended in 100 ml chloroform- 
methanol (9:1), and a 10 ml aliquot was concentrated under a stream of nitrogen. 
The concentrated extract was then chromatographed on a silica gel plate (5 x 20 cm) 
using solvent system A. The plate was developed three times (multiple pass) for effective 
resolution of the metabolites, and the radioactive areas were eluted with ethanol-con- 
centrated NH,OH (8:2). The eluents were evaporated to dryness and counted for 
radioactivity. 
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RESULTS 
The thin-layer radiochromatogram (Fig. 3) prepared from the chloroform-methanol 
(9 : 1) extract of urine from the caffeine injected rats revealed the presence of at least 5 
major radioactive areas corresponding to the 6 bands A-F visible under UV light. 
These radioactive areas upon elution with ethanol-concentrated NH40H (8:2) and 
rechromatography in solvent system B were found to be homogeneous except for the 
radioactive areas corresponding to the bands C and D which indicated the presence of 
two radioactive compounds. 
FIG. 3. Radiochromatogram scan of caffeine metabolites separated from rat urine by extraction with 
chloroform-methanol (9:l). Developed in solvent system A (CHC&EtOH, 9:l) on precoated TLC 
sheets of silica gel F-254 on aluminum. 
Thin-Layer Chromatography 
Table 1 lists the R, values ofcaffeine and 13 possible metabolites in the solvent systems 
A and B. Comparison of the Rf values of the isolated metabolites of caffeine and the 
known compounds (Tables 1 and 2) indicated the presence of caffeine, theophylline, 
theobromine and paraxanthine in the chloroform-methanol extract of rat urine. 
Metabolite A (R, 0.06 in solvent system A and Rf 0.40 in solvent system B) and metabo- 
lite B (R, 0.08 in solvent system A and 0.50 in solvent system B) do not seem to have 
R, values comparable with any of the known methylated xanthine and uric acid deriva- 
tives (II-XIV) examined. 
Ultraviolet Absorption 
The ultraviolet absorptions of caffeine and 13 possible metabolites in ethanol and 
ethanolic sodium hydroxide are given in Table 1. The ultraviolet absorptions of the 
compounds C to F showed absorption maxima and minima consistent with that of 
paraxanthine, theobromine, theophylline and caffeine, respectively, thereby indicating 
these compounds as the metabolites of caffeine in the rat. Metabolite A showed an 
absorption maximum at 262.5 nm which did not change in the alkaline medium. The 
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TABLE 1 
TLC AND UV CHARACTERISTICS OF POSSIBLE METABOLITES OF CAFFEINE 
Compounds (number) 
UV absorption spectra (nm) 
R, x 100 in - ---- - ~-~ 
solvents EtOH EtOH + 0.01 N NaOH 
.- ~~~~~ ~~- ~- . - 
A” B” max min max min 
7-Methyluric acid (XV) 0 0 296 266 296 266 
3-Methyluric acid (XIV) 0 0 296 266 297 267 
I-Methyluric acid (XIII) 3 3 295 266 295 267 
3,7-Dimethyluric acid (XII) 9 4 297 265 297 265 
7-Methylxanthine (VII) 11 4 268 241 271 243 
3-Methylxanthine (VI) 12 5 272 242 274 245 
1,3-Dimethyluric acid (X) 15 4 297 267 297 267,240(S) 
1,7-Dimethyluric acid (XI) 15 4 295 266.5 295 266.5 
I-Methylxanthine (V) 16 7 268 240 275,245 260,23 1 
Paraxanthine (III) 21 14 269.5 242 293 260 
Theobromine (II) 23 46 270 245 270 255 
Theophylline (IV) 28 19 272 242 274 244 
1,3,7-Trimethyluric acid (IX) 37 6 296 262 297 263,242(S) 
Caffeine (I) 47 73 273 244 273 244 
y  Solvent system A : chloroform-ethanol (9 : 1). 
’ Solvent system B: chloroform-acetone-n-butanol-concentrated NH,OH (30: 30:40:10). 
TABLE 2 
TLC AND UV CHARACTERISTICS OF THE CAFFEINE METABOLITES EXTRACTED 
FROM RAT URINE BY CHLOROFORM-METHANOL (9 : 1) 
UV absorption spectra (nm) 
R, x 100 in EtOH + 0.01 N 
solvent EtOH NaOH 
Metabolites A” Bb Max Min Max Min 
._____- ---- 
A 6 40 262.5 237 262.5 240 
B 8 50 270 254 279 260 
C (Paraxanthine) 21 14 269.5 242 293 260 
D (Theobromine) 23 46 270 245 270 255 
E (Theophylline) 28 19 212 242 214 244 
F (Caffeine) 47 73 273 244 273 244 
’ Solvent system A: chloroform-ethanol (9:l). 
h Solvent system B: chloroform-acetone-n-butanol-concentrated NH,OH (30: 30:40:10). 
absorption maximum at 270 nm exhibited by metabolite B was found to shift to 279 nm 
upon basification, suggesting the presence of an ionizable hydrogen. 
Mass Spectrometry 
The mass spectra of the isolated metabolites C to F are listed in Table 3, and these 






































































































































































































































































































































METABOLISM OF CAFFEINE 727 
comparison with the spectra of the known reference compounds (Rao et al., 1972). 
Trace quantities of 3-methyluric acid and 1,3,7-trimethyluric acid were also identified 
by mass spectrometry (Table 3) in the fraction designated metabolite B. 
The metabolites A (molecular ion at m/e 212) and B (molecular ion at m/e 200) 
do not appear to be identical with any of the known methylated xanthine and uric acid 
derivatives (II-XIV) examined (Rao et al., 1972). The molecular ion in the mass 
spectrum of the metabolite A readily looses a molecule of water as indicated by the 
presence of the fragment ion at m/e 194. Further fragmentations of the ion of m/e 194 
is reminiscent of caffeine (molecular ion at m/e I94), in particular the presence of the 
ion at m/e 109 (Table 3). The mass spectrum of the metabolite B appears to be quite 
different from the spectra of the known methylxanthines and methyluric acids, which 
suggests the absence of intact purine ring system in this metabolite. 
Quantitation of the Metabolites 
The percent urinary excretions of caffeine and its metabolites, after a single ip dose 
(40 mg/kg) of caffeine-3H in the rat, are given in Table 4. Metabolite A (I 1.4 %) is the 
major metabolite, followed in concentration by paraxanthine (8.8 ‘A), theobromine 
(5.1%), and theophylline (1.2%). Trace quantities of 1,3,7-trimethyluric acid and 
3-methyluric acid were detected as impurities in metabolite B. The excretion of caffeine 
(8.8%) may be artificially elevated due to the conversion of metabolite A to caffeine 
under isolation conditions. 
TABLE 4 
PERCENT URINARY EXCRETION OF CAFFEINE-3H 
AND ITS METABOLITES AFTER A SINGLE 
INTRAPERITONEAL DOSE (40 mg/kg) OF 
CAFFEINE-3H IN THE RAT 
Metabolites 
Activity recovered 
(‘% of dose) 
A 11.4 
B 1.3 
C (paraxanthine) 8.8 
D (theobromine) 5.1 
E (theophylline) 1.2 
F (caffeine) 8.8 
3-Methyluric acid Traceb 
1,3,7-Trimethyluric acid Trace’ 
’ The values are averages of 4 rats. 
b Detected by mass spectrometry as trace con- 
stituents in the fraction designated metabolite B. 
Total radioactivity of the compounds reported here constitute about 37 % of injected 
caffeine-3H. Approximately 30% of the radioactivity excreted in rat urine was not 
extracted by chloroform-methanol and therefore is not included in this study. 
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DISCUSSION 
The chloroform-methanol (9 :l) extract of rat urine contained about 37 % of the 
radioactivity from the ingested caffeine-3H. Approximately 13% of the extracted 
radioacitivity was accounted for by the three mono-N-demethylated products, para- 
xanthine (8.8 %), theobromine (5.1%) and theophylline (1.2%). In this regard, caffeine 
metabolism in the rat parallels that observed in man (Cornish and Christman, 1957; 
Schmidt and Schoyerer, 1966; Warren, 1969), and in both cases the 3-N-demethylated 
product, paraxanthine, is the major metabolite among the dimethylxanthine products. 
The dimethylxanthines, theophylline, theobromine and paraxanthine, have not been 
reported earlier as metabolites of caffeine in rat urine. However, Otomo (1969) has 
reported the presence of theophylline in the serum of the rats receiving caffeine ip for 
a period of 10 days. In man and the rabbit, caffeine is known to be metabolized to 
paraxanthine and theobromine (Cornish and Christman, 1957; Schmidt and Schoyerer, 
1966), while theophylline has been previously reported as a metabolite of caffeine in 
dog urine (Parke, 1968). 
Although monomethylxanthines such as I-methylxanthine are reported in the 
literature as the urinary metabolites of caffeine in the rat (Otomo, 1959), the rabbit 
and man (Cornish and Christman, 1957; Schmidt and Schoyerer, 1966), we have not 
detected monomethylxanthines in the chloroform-methanol extracts of rat urine. 
Trace quantities of 3-methyluric acid and 1,3,7-trimethyluric acid, however, were 
found to be present in the fraction containing metabolite B, and this is in agreement 
with earlier studies (Otomo, 1959). 
In addition to the known metabolites described above, we have isolated two unknown 
metabolites, A (11.4 %) and B (1.3 ‘A) from the chloroform-methanol (9:l) extract of 
rat urine. Metabolite A appears to be a polar compound, and it readily dehydrates to 
caffeine under TLC and mass spectrometric conditions. Based upon its mass spectral 
fragmentation pattern, we have tentatively identified metabolite A as 1,3,7-trimethyl- 
dihydrouric acid. Metabolite B exhibits mass spectral characteristics quite different 
from those of methylxanthines and methyluric acids. This may be taken as an indication 
of the absence of the intact purine ring system in metabolite B. Further work to estab- 
lish the structures of these unknown metabolites is in progress and will be reported 
separately. 
The proposed pathways for the metabolism of caffeine in the rat are given in Fig. 4. 
Caffeine is metabolized to paraxanthine, theobromine and theophylline by the appro- 
priate mono-N-demethylation reaction. The oxygenation of the C-8 carbon in the 
caffeine molecule may proceed via the 1,3,7-trimethyldihydrouric acid intermediate 
(metabolite A). Dehydrogenation of this intermediate would lead to 1,3,7-trimethyluric 
acid, which then undergoes demethylation to form di- and monomethyluric 
acid. 
In all earlier investigations reported in the literature, caffeine metabolites have been 
generally identified on the basis of chromatographic and UV methods. The application 
of TLC in conjunction with mass spectrometry appears to be a convenient and rapid 
method for the identification of caffeine and its metabolites. Further, microgram 
quantities of these metabolites isolated from TLC plates could be directly identified 
by the mass spectrometric method without further purification or derivatization. 

















FIG. 4. Proposed pathways for the metabolism of caffeine-3H in the rat. 
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